CMAJ2d
Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients with type 2 diabetes
In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...
CMAJ2d
Predictors of cost-related medication nonadherence in Canada: a repeated cross-sectional analysis of the Canadian Community Health Survey
Background: In Canada, many patients face substantial out-of-pocket costs for prescription medication, which may affect their ability to take their medications as prescribed. We sought to conduct a ...
CMAJ2d
The first, fragile foundations of national pharmacare in Canada
See related research at On Oct. 10, 2024, Bill C-64 — comprising the first concrete measures to implement universal, single-payer, public pharmacare in Canada — became law.[1][2] As an initial step ...
CMAJ2d
People who use wheelchairs
Self-reflection on attitudes and beliefs may mitigate bias and discrimination. Structural changes — for which funding is sometimes available — can ensure universal accessibility. Equitable access to h ...
CMAJ3d
Table of Contents
Five Things to Know About ...: Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients with type 2 diabetes ...
CMAJ2d
Orthostatic hypotension in a patient with HIV: uncovering adrenal insufficiency from fluticasone–cobicistat interactions
KEY POINTS A 72-year-old man presented to the emergency department with a 2-week history of hypotension, postural dizziness, and muscle weakness. He had a medical history of HIV, lipodystrophy, ...
CMAJ9d
Perilunate dislocation
A 74-year-old man presented to our orthopedic department with pain and swelling in his right hand after falling down a mountainside and landing on his outstretched hand that day. On initial ...